PFN2 silencing has suppressed proliferation, invasiveness, and migratory potential of HNSCC cells, possibly through reduction of Akt and GSK-3β phosphorylation as well as decrease in β-catenin levels. Here, PFN2 is linked to head and neck squamous cell carcinoma.